Causes, presentation and outcome of lesional adult onset mediotemporal lobe epilepsy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 8, 2009, Pages 894-899

  Soeder, B M ^a   Gleissner, U ^a   Urbach, H ^a   Clusmann, H ^a   Elger, C E ^a   Vincent, A ^b   Bien, C G ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AMYGDALOID NUCLEUS; ANTICONVULSANT THERAPY; ARTICLE; BRAIN DAMAGE; BRAIN SURGERY; BRAIN TUMOR; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; HIPPOCAMPAL SCLEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MEMORY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; TEMPORAL LOBE EPILEPSY; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; AGED; FEMALE; HIPPOCAMPUS; MALE; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RETROSPECTIVE STUDY; SCLEROSIS; TEMPORAL LOBE;

ADULT; AGE OF ONSET; AGED; AMYGDALA; ANTICONVULSANTS; BRAIN NEOPLASMS; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEUROSURGICAL PROCEDURES; PSYCHOMOTOR PERFORMANCE; RETROSPECTIVE STUDIES; SCLEROSIS; TEMPORAL LOBE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67849094326     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.165860     Document Type: Article

References (41)

1. Spielmeyer W. Die Pathogenese des epileptischen Krampfes. Histopathologischer Teil. Z ges Neurol Psychiat 1927;109:501-20.
2. Falconer MA, Serafetinides EA, Corsellis JAN. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964;10:233- 48.
3. Margerison JH, Corsellis JA. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530.
4. Bruton CJ. The neuropathology of temporal lobe epilepsy. Oxford: Oxford University Press, 1988.
5. Wolf HK, Campos MG, Zentner J, et al. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol 1993;52:499-506.
6. Peiffer J. Neuronale Schäden durch Epilepsien. Klinisch-neuropathologische Korrelationsversuche zur Frage der Krampfschäden beim Menschen. Stuttgart: Georg Thieme Verlag, 1993.
7. Õun A, Haldre S, Mägi M. Incidence of adult epilepsy in Estonia. Acta Neurol Scand 2003;108:245-51.
8. Olafsson E, Ludvigsson P, Gudmundsson G, et al. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005;4:627-34.
9. Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 2007;69:1236-44.
10. French JA, Williamson PD, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993;34:774-80.
11. Mathern GW, Babb TL, Vickrey BG, et al. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995;118:105-18.
12. Urbach H. Imaging of the epilepsies. Eur Radiol 2005;15:494-500.
13. Ravo Diagnostika. Immuno-(Dot)-Blot for the detection of the paraneoplastic autoantibodies anti-HuD, anti-Yo, anti-Ri, anti-CV2 (CRMP5), anti-Amphiphysin, anti-Ma1 and anti-Ma2. http://www.ravo.de/en/Produkte/ravo- pns-blot-zu-immuno-verst.php (accessed 12 May 2009).
14. Moll JW, Antoine JC, Brashear HR, et al. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands. Neurology 1995;45:1937-41.
15. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-46.
16. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12.
17. Helmstaedter C, Lendt M, Lux S. VLMT: Verbaler Lern- und Merkfähigkeitstest. Testhandbuch. Göttingen: Hogrefe, 2000.
18. Helmstaedter C, Pohl C, Elger CE. Eine modifizierte Version des Diagnostikums für Cerebralschäden (DCS) zur Diagnostik räumlich-visueller Gedächtnisdefizite bei Patienten mit Temporallappenepilepsie. In: Scheffner D, ed. Epilepsie 90. Reinbek: Einhorn-Presse, 1991:272-9.
19. Brickenkamp R. Test d2 Aufmerksamkeits-Belastungs-Test. Göttingen: Hogrefe, 1978.
20. Reitan RM. Trail Making Test. Manual for administration and scoring. South Tucson, AZ: Reitan Neuropsychology Laboratory, 1992.
21. Kleihues P, Cavenee WK. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Nervous System. Lyon: IARC-Press, 2000.
22. Wieser HG, ILAE commission on neurosurgery for epilepsy. ILAE commission report: Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004;45:695-714.
23. Duncan JS. Imaging and epilepsy. Brain 1997;120:339- 77.
24. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.
25. Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology 2006;48:380-6.
26. Diaz-Arrastia R, Agostini MA, Frol AB, et al. Neurophysiologic and neuroradiologic features of intractable epilepsy after traumatic brain injury in adults. Arch Neurol 2000;57:1611-16.
27. Kral T, Clusmann H, Urbach J, et al. Preoperative evaluation for epilepsy surgery (Bonn Algorithm). Zentralbl Neurochir 2002;63:106-10.
28. Hermann BP, Seidenberg M, Schoenfeld J, et al. Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery. Epilepsia 1996;37:942-50.
29. Eng JA, Frosch MP, Choi K, et al. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250-6.
30. Loiseau J, Loiseau P, Duche B, et al. A survey of epileptic disorders in southwest France: seizures in elderly patients. Ann Neurol 1990;27:232-7.
31. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73.
32. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
33. Bower SP, Vogrin SJ, Morris K, et al. Amygdala volumetry in "imaging-negative" temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003;74:1245-9.
34. Miller LA, McLachlan RS, Bouwer MS, et al. Amygdalar sclerosis: preoperative indicators and outcome after temporal lobectomy. J Neurol Neurosurg Psychiatry 1994;57:1099-105.
35. Zentner J, Wolf HK, Helmstaedter C, et al. Clinical relevance of amygdala sclerosis in temporal lobe epilepsy. J Neurosurg 1999;91:59-67.
36. Tebartz van Elst L, Woermann FG, Lemieux L, et al. Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala. Brain 2000;123:234-43.
37. Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 1997;41:378-86.
38. Choi JY, Chang JW, Park YG, et al. A retrospective study of the clinical outcomes and significant variables in the surgical treatment of temporal lobe tumor associated with intractable seizures. Stereotact Funct Neurosurg 2004;82:35-42.
39. Baldauf CM, Cukiert A, Argentoni M, et al. Surgical outcome in patients with refractory epilepsy associated to MRI-defined unilateral mesial temporal sclerosis. Arq Neuropsiquiatr 2006;64:363-8.
40. Lowe AJ, David E, Kilpatrick CJ, et al. Epilepsy surgery for pathologically proven hippocampal sclerosis provides long-term seizure control and improved quality of life. Epilepsia 2004;45:237-42.
41. Semah F, Picot M-C, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51:1256-62.